Opioids administered or prescribed in 35.0 and 32.5 percent of U.S. visits in 2016, respectively, compared with 24.5 and 13.5 percent in 2022

Discontinuation of GLP-1 receptor agonists suggested before conception rather than between start of pregnancy and end of first trimester

Maternal use of valproate, phenobarbital, and topiramate early in pregnancy linked to increased risk versus lamotrigine use

By I. Edwards HealthDay ReporterFRIDAY, July 18, 2025 (HealthDay News) — After years of legal battles and health concerns, Juul Labs has the go-ahead to sell some of its electronic cigarettes in the United States.The U.S. Food and Drug Administration (FDA) said that it will allow Juul to market its …

By I. Edwards HealthDay ReporterFRIDAY, July 18, 2025 (HealthDay News) — A new IVF technique helped eight babies in the U.K. avoid serious inherited diseases, and scientists are calling it a breakthrough.All eight children were born using a method that uses DNA from three people: the mother, the father and …

So far, 11 people have been sickened and four hospitalized; no deaths have been reported

Lower risk for moderate-to-severe gastroenteritis seen during seven days after enrollment with oral ondansetron versus placebo

Biggest declines seen in populations usually associated with higher vaccine uptake

Reported symptoms included dizziness, nausea, vertigo, nervousness

Risk ratios were 1.27 and 1.55 for GERD and its complications during a median follow-up of three years for GLP-1 RA versus SGLT-2 inhibitor users